Vaccination against periodontitis: the saga continues

References

• Playfair J. Vaccination. In: Immunology. Roitt I, Brostoff J, Male D (Eds). Mosby, London, UK, 19.1–19.10 (1998).
   Google Scholar
• Loesche WJ. Chemotherapy of dental plaque infections. Oral Sci. Rev.9, 65–107 (1976).
   PubMedGoogle Scholar
• Loesche WJ. Clinical and microbiological agents of chemotherapeutic gents used according to specific plaque hypothesis. J. Dent. Res.58(12), 2404–2412 (1979).
   PubMed Web of Science ®Google Scholar
• Theilade E. The non-specific theory in microbial etiology of inflammatory periodontal disease. J. Clin. Periodontol.13(10), 905–911 (1986).
   PubMed Web of Science ®Google Scholar
• Nãrskov-Lauritsen M, Kilian M. Reclassification of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, Haemophilus paraphrophilus and Haemophilus segnis as Aggregatibacter actinomycetemcomitans gen. nov., comb. nov., Aggregatibacter aphrophilus comb. nov. and Aggregatibacter segnis comb. nov., and emended description of Aggregatibacter aphrophilus to include V factor-dependent and V factor-independent isolates. Int. J. Syst. Evol. Microbiol.56(9) 2135–2146 (2006).
   PubMed Web of Science ®Google Scholar
• Moritz AJ, Cappelli D, Lantz MS, Holt SC, Ebersole JL. Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature induced periodontitis in Macaca fascicularis. J. Periodontol.69(6), 686–697 (1998).
   PubMed Web of Science ®Google Scholar
• Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J. Clin. Periodontol.25(2), 134–144 (1998).
   PubMed Web of Science ®Google Scholar
• Slots J. Systemic antibiotics in periodontics. J. Periodontol.75(11), 1553–1565 (2004).
   PubMed Web of Science ®Google Scholar
• Parra B, Slots J. Detection of human viruses in periodontal pockets using polymerase chain reaction. Oral Microbiol. Immunol.11(5), 289–293 (1996).
   PubMedGoogle Scholar
• Contreras A, Umeda M, Chen C, Bakker I, Morrison LJ, Slots J. Relationship between herpesviruses and adult periodontitis and periodontopathic bacteria. J. Periodontol.70(5), 478–484 (1999).
   PubMed Web of Science ®Google Scholar
• Kubar A, Saygun I, Yapar M, Ozdemir A, Slots J. Real-time PCR quantification of cytomegalovirus in aggressive periodontitis lesions using TaqMan technology. J. Periodontal Res.39(2), 81–86 (2004).
   PubMed Web of Science ®Google Scholar
• Ling LJ, Ho CC, Wu CY, Chen YT, Hung SL. Association between human herpesviruses and the severity of periodontitis. J. Periodontol.75(11), 1479–1485 (2004).
   PubMed Web of Science ®Google Scholar
• Loubinoux J, Bisson-Boutelliez C, Miller N, Le Faou AE. Isolation of the provisionally named Desulfovibrio fairfieldensis from human periodontal pockets. Oral Microbiol. Immunol.17(5), 321–323 (2002).
   PubMedGoogle Scholar
• Lepp PW, Brinig MM, Ouverney CC, Palm K, Armitage GC, Relman DA. Methanogenic archaea and human periodontal disease. Proc. Natl Acad. Sci. USA101(16), 6176–6181 (2004).
   PubMed Web of Science ®Google Scholar
• Dzink JL, Socransky SS, Haffajee AD. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal disease. J. Clin. Periodontol.15(5), 316–323 (1988).
   PubMed Web of Science ®Google Scholar
• Sundqvist G. Pathogenicity and virulence of black-pigmented Gram-negative anaerobes. FEMS Immunol. Med. Microbiol.6(2–3), 125–137 (1993).
   PubMedGoogle Scholar
• Persson GR, Engel D, Whitney C, Darveau R, Weinberg A, Brunsvold M. Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect. Immun.62(3), 1026–1031 (1994).
   PubMed Web of Science ®Google Scholar
• Houston LS, Lukehart SA, Persson GR, Page RC. Function of anti-Porphyromonas gingivalis immunoglobulin classes in immunized Macaca fascicularis. Oral Microbiol. Immunol.14(2), 86–91 (1999).
   PubMedGoogle Scholar
• Page RC. Vaccination and periodontitis: myth or reality. J. Int. Acad. Periodontol.2(2), 31–43 (2000).
   PubMedGoogle Scholar
• Gibson FC, Gonzalez DA, Wong J, Genco CA. Porphyromonas gingivalis specific immunoglobulin G prevents Porphyromonas gingivalis elicited oral bone loss in a murine model. Infect. Immun.72(4), 2408–2411 (2004).
   PubMed Web of Science ®Google Scholar
• Travis J, Pike R, Imamura T, Potempa J. Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J. Periodontal Res.32(1 Pt 2), 120–125 (1997).
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Yoneda M, Okamoto K, Maeda K, Yamamoto K. Purification and characterization of a novel arginine-specific cysteine protease (argingipain) involved in the pathogenesis of periodontal disease from the culture supernatant of Porphyromonas gingivalis. J. Biol. Chem.269(33), 21371–21378 (1994).
   PubMed Web of Science ®Google Scholar
• Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J. Periodontol.74(1), 111–118 (2003).
   PubMed Web of Science ®Google Scholar
• Discipio RG, Daffern PJ, Kawahara M, Pike R, Travis J, Hugli TE. Activation of complement component C5 by cysteine proteases from Porphyromonas gingivalis. Prior oxidation of C5 augments proteinase digestion of C5. Immunology87(4), 660–667 (1996).
   PubMed Web of Science ®Google Scholar
• Gibson FC, Genco CA. Prevention of Porphyromonas gingivalis induced oral bone loss following immunization with gingipain R1. Infect. Immun.69(12), 7959–7963 (2001).
   PubMed Web of Science ®Google Scholar
• Rajapakse PS, O’Brien-Simpson NM, Slakeski N, Hoffmann B, Reynolds EC. Immunization with the RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis protects against periodontal bone loss in the rat periodontitis model. Infect. Immun.70(5), 2480–2486 (2002).
   PubMed Web of Science ®Google Scholar
• De Carlo AA, Huang Y, Collyer CA, Langley DB, Katz J. Feasibility of an HA2 domain-based periodontitis vaccine. Infect. Immun.71(1), 562–566 (2003).
   PubMed Web of Science ®Google Scholar
• Inagaki S, Ishihara K, Takahashi J, Yasaki Y, Yamada S, Okuda K. Antibody response of periodontitis patients to gingipains of Porphyromonas gingivalis.J. Periodontol.74(10), 1432–1439 (2003).
   PubMed Web of Science ®Google Scholar
• Genco CA, Odusanya BM, Potempa J, Mikolajczyk-Pawlinska J, Travis J. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect. Immun.66(9), 4108–4114 (1998).
   PubMed Web of Science ®Google Scholar
• O’Brien-Simpson NM, Paolini RA, Reynolds EC. RgpA-Kgp peptide based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model. Infect. Immun.68(7), 4055–4063 (2000).
   PubMed Web of Science ®Google Scholar
• Kuboniwa M, Amano A, Shizukuishi S, Nakagawa I, Hamada S. Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection. Infect. Immun.69(5), 2972–2979 (2001).
   PubMed Web of Science ®Google Scholar
• O’Brien-Simpson NM, Pathirana RD, Paolini RA et al. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J. Immunol.175(6), 3980–3989 (2005).
   PubMed Web of Science ®Google Scholar
• Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev.62(4), 1244–1263 (1998).
   Google Scholar
• Hamada N, Sojar HT, Cho MI, Genco RJ. Isolation and characterization of a minor fimbria from Porphyromonas gingivalis. Infect. Immun.64(11), 4788–4794 (1996).
   PubMed Web of Science ®Google Scholar
• Ogawa T, Yasuda K, Yamada K, Mori H, Ochiai K, Hasegawa M. Immunochemical characterization and epitope mapping of a novel fimbrial protein (Pg-II fimbria) of Porphyromonas gingivalis. FEMS Immunol. Med. Microbiol.11(3), 247–255 (1995).
   PubMedGoogle Scholar
• Evans RT, Klausen B, Sojar HT, Bedi GS, Sfintescu C, Ramamurthy NS. Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect. Immun.60(7), 2926–2935 (1992).
   PubMed Web of Science ®Google Scholar
• Baum BJ, O’Connell BC. The impact of gene therapy on dentistry. J. Am. Dent. Assoc.126(2), 179–189 (1995).
   PubMed Web of Science ®Google Scholar
• Fan Q, Sim ST, Sojar H, Genco R, Page RC. Fimbriae of Porphyromonas gingivalis induce opsonic antibodies that significantly enhance phagocytosis and killing by human polymorphonuclear leukocytes. Oral Microbiol. Immunol.16(3), 144–152 (2001).
   PubMedGoogle Scholar
• Choi JI, Schifferle RE, Yoshimura F, Kim BW. Capsular polysaccharide-fimbrial protein conjugate vaccine protects against Porphyromonas gingivalis infection in SCID mice reconstituted with human peripheral blood lymphocytes. Infect. Immun.66(1), 391–393 (1998).
   PubMed Web of Science ®Google Scholar
• Gonzalez D, Tzianabos AO, Genco CA, Gibson FC. Immunization with Porphyromonas gingivalis capsular polysaccharide prevents Porphyromonas gingivalis elicited oral bone loss in a murine model. Infect. Immun.71(4), 2283–2287 (2003).
   PubMed Web of Science ®Google Scholar
• Takazoe I, Nakamura T, Okuda K. Colonization of the subgingival area by Bacteroides gingivalis. J. Dent. Res.63(3), 422–426 (1984).
   PubMed Web of Science ®Google Scholar
• Slots J, Gibbons RJ. Attachment of Bacteroides melaninogenicus subspecies asaccharolyticus to oral surfaces and its possible role in colonization of the mouth and of periodontal pockets. Infect. Immun.19(1), 254–264 (1978).
   PubMed Web of Science ®Google Scholar
• Mouton C, Bouchard D, Deslauriers M, Lamonde L. Immunochemical identification and preliminary characterization of a nonfimbrial hemagglutinating adhesin of Bacteroides gingivalis. Infect. Immun.57(2), 566–573 (1989).
   PubMed Web of Science ®Google Scholar
• Ellen RP, Grove DA. Bacteroides gingivalis vesicles bind to and aggregate Actinomyces viscosus. Infect. Immun.57(5), 1618–1620 (1989).
   PubMed Web of Science ®Google Scholar
• Gibbons RJ, Nygaard M. Interbacterial aggregation of plaque bacteria. Arch. Oral Biol.15(12), 1397–1400 (1970).
   PubMedGoogle Scholar
• Maeba S, Otake S, Namikoshi J, Shibata Y, Hayakawa M, Abiko Y, Yamamoto M. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit co-aggregation by Porphyromonas gingivalis. Vaccine23(19), 2513–2521 (2005.
   PubMed Web of Science ®Google Scholar
• Namikoshi Y, Otake S, Maeba S, Hayakawa M, Abiko Y, Yamamoto M. Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits co-aggregation activity of P. gingivalis. Vaccine22(2), 250–256 (2003).
   PubMed Web of Science ®Google Scholar
• Saito S, Hiratsuka K, Hayakawa M, Takiguchi H, Abiko Y. Inhibition of a Porphyromonas gingivalis colonization factor between Actinomyces viscous ATCC19246 by monoclonal antibodies against recombinant 40-kDa outer membrane protein. Gen. Pharmacol.28(5), 675–680 (1997).
   PubMedGoogle Scholar
• Abiko Y, Ogura N, Matsuda U, Yanagi K, Takiguchi H. A human monoclonal antibody which inhibits the co-aggregation activity of Porphyromonas gingivalis. Infect. Immun.65(9), 3966–3969 (1997).
   PubMed Web of Science ®Google Scholar
• Saito S, Hayakawa M, Takiguchi H, Abiko Y. Opsonophagocytic effect of antibody against recombinant conserved 40-kDa outer membrane protein of Porphyromonas gingivalis.J. Periodontol.70(6), 610–617 (1999).
   PubMed Web of Science ®Google Scholar
• Ross BC, Czajkowski L, Hocking D et al. Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine19(30), 4135–4142 (2001).
   PubMed Web of Science ®Google Scholar
• Ross BC, Czajkowski L, Vandenberg KL, Camuglia S, Woods J, Agius C. Characterization of two outer membrane protein antigens of Porphyromonas gingivalis that are protective in a murine lesion model. Oral Microbiol. Immunol.19(1), 6–15 (2004).
   PubMedGoogle Scholar
• Chu L, Bramanti TE, Ebersole JL, Holt SC. Hemolytic activity in the periodontopathogen Porphyromonas gingivalis kinetics of enzyme release and localization. Infect. Immun.59(6), 1932–1940 (1991).
   PubMed Web of Science ®Google Scholar
• Okuda K, Kato T, Naito Y, Takazoe I, Kikuchi Y, Nakamura T. Protective efficacy of active and passive immunizations against experimental infection in ligated hamsters. J. Dent. Res.67(5), 807–811 (1988).
   PubMed Web of Science ®Google Scholar
• Booth V, Ashley FP, Lehner T. Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. Infect. Immun.64(2), 422–427 (1996).
   PubMed Web of Science ®Google Scholar
• Booth V, Lehner T. Characterization of the Porphyromonas gingivalis antigen recognized by a monoclonal antibody which prevents colonization by the organism. J. Periodontal Res.32(1 Pt 1), 54–60 (1997).
   PubMed Web of Science ®Google Scholar
• Shibata Y, Kurihara K, Takiguchi H, Abiko Y. Construction of a functional ScFv antibody against a hemagglutinin from Porphyromonas gingivalis. Infect. Immun.66(5), 2207–2312 (1998).
   PubMed Web of Science ®Google Scholar
• Hosogi Y, Hayakawa M, Abiko Y. Monoclonal antibody against Porphyromonas gingivalis hemagglutinin inhibits hemolytic activity. Eur. J. Oral Sci.109(2), 109–113 (2001).
   PubMed Web of Science ®Google Scholar
• Kaizuka K, Hosogi Y, Hayakawa M, Shibata Y, Abiko Y. Human monoclonal antibody inhibits Porphyromonas gingivalis hemagglutinin activity. J. Periodontol.74(1), 38–43 (2003).
   PubMed Web of Science ®Google Scholar
• Shibata Y, Hosogi Y, Hayakawa M, Hori N, Kamada M, Abiko Y. Construction of novel human monoclonal antibodies neutralizing Porphyromonas gingivalis hemagglutination activity using transgenic mice expressing human Ig loci. Vaccine23(29), 3850–3856 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang P, Yang QB, Balkovetz DF et al. Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis. Vaccine23(39), 4734–4744 (2005).
   PubMed Web of Science ®Google Scholar
• Harano K, Yamanaka A, Okuda K. An antiserum to a synthetic fimbrial peptide of Actinobacillus actinomycetemcomitans blocked adhesion of the microorganism. FEMS Microbiol. Lett.130(2–3), 279–285 (1995).
   PubMed Web of Science ®Google Scholar
• Takamatsu-Matsushita N, Yamaguchi N, Kawasaki M, Yamashita Y, Takehara T, Koga T. Immunogenicity of Actinobacillus actinomycetemcomitans serotype b-specific polysaccharide-protein conjugate. Oral Microbiol. Immunol.11(4), 220–225 (1996).
   PubMedGoogle Scholar
• Herminajeng E, Asmara W, Yuswanto, Barid I, Sosroseno W. Protective humoral immunity induced by surface associated material from Actinobacillus actinomycetemcomitans in mice. Microbes Infect.3(12), 997–1003 (2001).
   PubMed Web of Science ®Google Scholar
• Tanner AC, Socransky SS, Goodson JM. Microbiota of periodontal pockets losing crestal alveolar bone. J. Periodontal Res.19(3), 279–291 (1984).
   PubMed Web of Science ®Google Scholar
• Cox SE, Holt SC, Ebersole JL. Characteristics of systemic antibody responses of nonhuman primates to cell envelope and cell wall antigens from periodontal pathogens. Oral Microbiol. Immunol.12(4), 204–211 (1997).
   PubMedGoogle Scholar
• Giardino A, Ebersole JL, Holt SC. Characteristics of systemic antibody responses of nonhuman primates following active immunization with Porphyromonas gingivalis, Prevotella intermedia and Bacteroides fragilis. Oral Microbiol. Immunol.11(2), 79–87 (1996).
   PubMedGoogle Scholar
• Gemmell E, Bird PS, Ford PJ et al. Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model. Oral Microbiol. Immunol.19(4), 247–51 (2004).
   PubMedGoogle Scholar
• Vasel D, Sims TJ, Bainbridge B, Houston L, Darveau R, Page RC. Shared antigens of Porphyromonas gingivalis and Bacteroides forsythus. Oral Microbiol. Immunol.11(4), 226–235 (1996).
   PubMedGoogle Scholar
• Lee JY, Yi NN, Kim US, Choi JS, Kim SJ, Choi JI. Porphyromonas gingivalis heat shock protein Vaccine reduces the alveolar bone loss induced by multiple periodontopathogenic bacteria. J. Periodontal Res.41(1), 10–14 (2006).
   PubMed Web of Science ®Google Scholar
• Sharma A, Sojar HT, Hruby DE, Kuramitsu HK, Genco RJ. Secretion of Porphyromonas gingivalis fimbrillin polypeptides by recombinant Streptococcus gordonii. Biochem. Biophys. Res. Commun.238(2), 313–316 (1997).
   PubMed Web of Science ®Google Scholar
• Sharma A, Honma K, Evans TR, Hruby DE. Oral immunization with recombinant Streptococcus gordonii expressing Porphyromonas gingivalis Fim A domains. Infect. Immun.69(5), 2928–2934 (2001).
   PubMed Web of Science ®Google Scholar
• Kozarov E, Miyashita N, Burks J, Cerveny K. Expression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica. Infect. Immun.68(2), 732–739 (2000).
   PubMed Web of Science ®Google Scholar
• Katz J, Black KP, Michalek SM. Host response to recombinant hemagglutinin B of Porphyromonas gingivalis in an experiment rat model. Infect. Immun.67(9), 4352–4359 (1999).
   PubMed Web of Science ®Google Scholar
• Nair SP, Meghji S, Reddi K, Poole S, Miller AD, Henderson B. Molecular chaperones stimulate bone resorption. Calcif. Tissue Int.64(3), 214–218 (1999).
   PubMed Web of Science ®Google Scholar
• Castellino F, Boucher PE, Eichelberg K. Receptor-mediated uptake of antigen/heat shock protein complexes class 1 antigen presentation via two distinct processing pathways. J. Exp. Med.191(11), 1957–1964 (2000).
   PubMed Web of Science ®Google Scholar
• Breivik T, Rook GA. Prevaccination with SRL172 (heat-killed Mycobacterium vaccae) inhibits experimental periodontal disease in wistar rats. Clin. Exp. Immunol.120(3), 463–467 (2000).
   PubMed Web of Science ®Google Scholar
• Breivik T, Rook GA. Treatment with SRL172 (heat-killed Mycobacterium vaccae) inhibits progression of established experimental periodontal disease in wistar rats. J. Periodontal Res.37(3), 210–214 (2002).
   PubMed Web of Science ®Google Scholar
• Breivik T, Rook GA. Oral treatment with SRP299 (killed Mycobacterium vaccae) inhibits experimental periodontal disease in wistar rats. J. Clin. Periodontol.30(11), 931–936 (2003).
   PubMed Web of Science ®Google Scholar
• Dusek DM, Progulske-Fox A, Whitlock J, Brown TA. Isolation and characterization of a cloned Porphyromonas gingivalis hemagglutinin from an avirulent strain of Salmonella typhimurium. Infect. Immun.61(3), 940–946 (1993).
   PubMed Web of Science ®Google Scholar
• Dusek DM, Progulske-Fox A, Brown TA. Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin. Infect. Immun.62(5), 1652–1657 (1994).
   PubMed Web of Science ®Google Scholar
• Kohler JJ, Pathangey LB, Brown TA. Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response. Oral Microbiol. Immunol.13(2), 81–88 (1998).
   PubMedGoogle Scholar
• Yamashita K, Eastcott JW, Taubman MA, Smith DJ, Cox DS. Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans-specific T helper cells on periodontal disease. Infect. Immun.59(4), 1529–1534 (1991).
   PubMed Web of Science ®Google Scholar
• Roberts FA, Laura S, Lukehart SA, Mancl LA, Persson R, Page RC. Periodontitis vaccine decreases local prostaglandin E2 levels in a primate model. Infect. Immun.72(2), 1166–1168 (2004).
   PubMed Web of Science ®Google Scholar
• Yang QB, Martin M, Michalek SM, Katz J. Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis. Infect. Immun.70(7), 3557–3565 (2002).
   PubMed Web of Science ®Google Scholar
• Arntzen CJ. High-tech herbal medicine: plant-based vaccines. Nat. Biotechnol.15(3), 221–222 (1997).
   PubMed Web of Science ®Google Scholar
• Ma JK, Hiatt A, Hein M et al. Generation and assembly of secretory antibodies in plants. Science268(5211), 716–719 (1995).
   PubMed Web of Science ®Google Scholar
• Ma JK, Hikmat BY, Wycoff K et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med.4(5), 601–606 (1998).
   PubMed Web of Science ®Google Scholar
• Shin EA, Lee JY, Kim TG, Park YK, Langridge WH. Synthesis and assembly of an adjuvanted Porphyromonas gingivalis fimbrial antigen fusion protein in plants. Protein Expr. Purif.47(1), 99–109 (2006).
   PubMed Web of Science ®Google Scholar